Christophe Bourdon

Chief Executive Officer
LEO Pharma A/S

Biography

With three decades of experience in the global biotech and pharmaceutical industry, Christophe has consistently focused on driving innovation, delivering patient impact, and building high-performing, diverse teams. His career has spanned leadership roles across Europe, North America, and Asia, giving him a broad international perspective. Improving the lives of patients remains his central focus.

Christophe joined LEO Pharma as CEO in April 2022. Since then, he has led the company through a strategic transformation, with a sharpened focus on innovation and external partnerships. Under his leadership, LEO Pharma has accelerated growth in key markets, revitalized its pipeline, and strengthened its culture – all while becoming a global leader in medical dermatology.

Prior to joining LEO Pharma, Christophe served as CEO at Orphazyme A/S. Earlier in his career, Christophe held a series of leadership roles at Amgen, including Senior Vice President and General Manager for the U.S. Oncology Business. He also worked at Alexion as Senior Vice President, EMEAC, leading the commercial development of ultra-orphan therapies across 40 countries.

Christophe earned his MBA from the International Institute for Management Development (IMD), Lausanne, Switzerland, and a B.A. from the Institut Superieur de Gestion/ISG, Paris, France. He is a French-German national.